Most of the normal meningeal tissue and all tumor tissues from schwannomas, solitary fibrous tumors/hemangiopericytomas and hemangioblastomas were negative for SSTR2 in our study, supporting the high specificity for SSTR2 as a biomarker for meningiomas in diagnostic routine. This evidence concerns the gene SSTR2 and hemangiopericytoma.